In SCCHN, salivary miR-93-5p may provide a potential biomarker for the post-radiation monitoring of SCCHN, and miR-93-5p has been shown to possess oncogenic function in laryngeal squamous cell carcinoma by targeting cyclin G2 25, 26. The gene discussed is CCNG2; the disease is laryngeal squamous cell carcinoma.